| Literature DB >> 32272651 |
Taissa Pereira-Dos-Santos1, David Roiz1, Ricardo Lourenço-de-Oliveira2, Christophe Paupy1.
Abstract
Mosquito-borne arboviruses are increasing due to human disturbances of natural ecosystems and globalization of trade and travel. These anthropic changes may affect mosquito communities by modulating ecological traits that influence the "spill-over" dynamics of zoonotic pathogens, especially at the interface between natural and human environments. Particularly, the global invasion of Aedes albopictus is observed not only across urban and peri-urban settings, but also in newly invaded areas in natural settings. This could foster the interaction of Ae. albopictus with wildlife, including local reservoirs of enzootic arboviruses, with implications for the potential zoonotic transfer of pathogens. To evaluate the potential of Ae. albopictus as a bridge vector of arboviruses between wildlife and humans, we performed a bibliographic search and analysis focusing on three components: (1) The capacity of Ae. albopictus to exploit natural larval breeding sites, (2) the blood-feeding behaviour of Ae. albopictus, and (3) Ae. albopictus' vector competence for arboviruses. Our analysis confirms the potential of Ae. albopictus as a bridge vector based on its colonization of natural breeding sites in newly invaded areas, its opportunistic feeding behaviour together with the preference for human blood, and the competence to transmit 14 arboviruses.Entities:
Keywords: Aedes albopictus; arboviruses; blood-feeding; bridge vector; emerging diseases; mosquito; spill-over; vector competence
Year: 2020 PMID: 32272651 PMCID: PMC7238240 DOI: 10.3390/pathogens9040266
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1Natural larval breeding sites exploited by Ae. albopictus. Number of reported natural breeding sites (black bars) and number of articles that reported natural breeding sites (grey areas).
Figure 2Boxplots showing the host feeding preferences (i.e., percentage of bites) of Ae. albopictus without taking into account host availability. (A) Mammals, humans, non-human mammals, and birds; (B) Humans, domestic animals, and wildlife. Black line: median.
Mean biting frequency by Aedes albopictus in animals classified according to biological class and family.
| Biological Class | Biological Family | Mean Frequency (%) |
|---|---|---|
| Aves | Phasianidae | 10.08 |
| Passeridae | 7.78 | |
| Anatidae | 7.5 | |
| Columbidae | 5.83 | |
| Sulidae | 2.33 | |
| Thamnophilidae | 1.49 | |
| Pycnonotidae | 1.39 | |
| Corvidae | 1.11 | |
| Ciconiidae | 1.0 | |
| Mammalia | Hominidae (Humans) | 59.83 |
| Muridae | 15.34 | |
| Canidae | 11.6 | |
| Herpestidae | 9.53 | |
| Bovidae | 8.9 | |
| Felidae | 8.49 | |
| Leporidae | 8.27 | |
| Sciuridae | 5.07 | |
| Suidae | 4.99 | |
| Didelphidae | 4.6 | |
| Equidae | 4.39 | |
| Cervidae | 4.15 | |
| Muridae/Soricidae | 3.43 | |
| Phyllostomidae | 2.99 | |
| Procyonidae | 2.71 | |
| Furipteridae | 1.49 | |
| Cricetidae | 0.61 | |
| Actinopterygii | Cobitidae | 1.11 |
| Amphibia | Salamandridae | 2.22 |
The mean frequencies were calculated using the data found in articles that described different Ae. albopictus populations biting different animals in different locations. As these articles do not describe the same biological families, the total mean bite frequency does not correspond to 100%.
Figure 3Transmission efficiency across studies that evaluated Ae. albopictus vector competence for different arboviruses. Bridge Vector*Virus and Epidemic Vector*Virus pairs were added to compare the transmission efficiency.
Infection rate, dissemination rate, dissemination efficiency, transmission rate, and transmission efficiency (mean and standard deviation) of Aedes albopictus for the indicated arboviruses, according to the inoculation method.
| Infection Method | Virus | Infection or Infection Rate | Dissemination Rate | Dissemination Efficiency | Transmission Rate | Transmission Efficiency | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | ||
| Host feeding | CHPV | 25.00 | 0.00 | ND | ND | ND | ND | ND | ND | 12.50 | 0.00 |
| EEEV | 75.36 | 35.35 | 85.19 | 25.66 | 76.99 | 33.58 | 40.00 | 0 | 57.17 | 20.15 | |
| JEV | ND | ND | ND | ND | ND | ND | ND | ND | 37.00 | 9.17 | |
| LACV | ND | ND | ND | ND | ND | ND | ND | ND | 23.86 | 6.69 | |
| MAYV | 11.88 | 3.31 | 20.00 | 0.00 | 4.07 | 1.32 | ND | ND | 3.46 | 0.69 | |
| OROV | 6.67 | 5.20 | ND | ND | ND | ND | ND | ND | ND | ND | |
| POTV | 26.26 | 17.06 | ND | ND | ND | ND | ND | ND | ND | ND | |
| RRV | 80.66 | 23.02 | ND | ND | ND | ND | ND | ND | 41.40 | 16.57 | |
| RVFV | 69.26 | 27.24 | 60.04 | 6.34 | 40.72 | 11.96 | 15.00 | 7.07 | 6.54 | 4.67 | |
| VEEV | 71.20 | 20.49 | 89.48 | 10.48 | 64.78 | 22.53 | 59.94 | 26.57 | 38.09 | 23.53 | |
| WNV | 73.41 | 23.81 | 94.39 | 3.91 | 69.80 | 23.98 | 82.72 | 11.49 | 68.63 | 18.62 | |
| Intrathoracic injection | AMTV | 100.00 | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| BUJV | 100.00 | ND | ND | ND | ND | ND | ND | ND | ND | ND | |
| CHIV | 96.88 | ND | ND | ND | ND | ND | ND | ND | ND | ND | |
| ICOV | 40.91 | ND | ND | ND | ND | ND | ND | ND | ND | ND | |
| ITPV | 81.25 | ND | ND | ND | ND | ND | ND | ND | ND | ND | |
| KARV | 94.12 | ND | ND | ND | ND | ND | ND | ND | ND | ND | |
| ORUV | 37.50 | 17.68 | ND | ND | ND | ND | ND | ND | 37.50 | 17.68 | |
| PACV | 100.00 | 0.00 | ND | ND | ND | ND | ND | ND | ND | ND | |
| RVFV | ND | ND | ND | ND | ND | ND | ND | ND | 15.93 | 7.35 | |
| SALV | 92.86 | 0.00 | ND | ND | ND | ND | ND | ND | ND | ND | |
| URUV | 94.12 | 0.00 | ND | ND | ND | ND | ND | ND | ND | ND | |
| Membrane feeding | CHIKV | 58.92 | 28.23 | 77.58 | 22.60 | 79.06 | 23.45 | 53.49 | 33.98 | 42.68 | 23.78 |
| CVV | 56.50 | 0.00 | 100.00 | 0.00 | ND | ND | 29.60 | 0.00 | 17.39 | 0.00 | |
| DENV-1 | 60.18 | 16.01 | 63.79 | 23.97 | 39.56 | 23.90 | 8.33 | 0.00 | 6.25 | 0.00 | |
| DENV-2 | 58.10 | 30.93 | 53.12 | 22.93 | 34.83 | 18.81 | 12.47 | 13.20 | 10.13 | 12.29 | |
| GETV | 100.00 | 0.00 | ND | ND | ND | ND | ND | ND | ND | ND | |
| JCV | 96.67 | 0.00 | 89.66 | 0.00 | 86.67 | 0.00 | 7.69 | 0.00 | 6.67 | 0.00 | |
| JEV | 91.98 | 10.72 | 90.79 | 14.56 | 84.63 | 19.92 | ND | ND | 40.50 | 15.98 | |
| KEYV | 91.89 | 0.00 | 91.18 | 0.00 | 83.78 | 0.00 | ND | ND | ND | ND | |
| LACV | 89.72 | 7.38 | 86.83 | 13.70 | 71.03 | 22.93 | 35.84 | 14.25 | 29.93 | 16.75 | |
| POTV | 93.55 | 6.59 | 96.13 | 3.21 | 89.86 | 5.96 | ND | ND | 14.67 | 7.00 | |
| RVFV | 10.53 | 0.00 | 25.00 | 0.00 | 2.63 | 0.00 | 100.00 | 0.00 | 2.63 | 0.00 | |
| TVTV | 28.00 | 0.00 | 85.71 | 0.00 | 24.00 | 0.00 | ND | ND | ND | ND | |
| USUV | 64.40 | 31.2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| WNV | 32.61 | 24.53 | 64.59 | 25.58 | 20.33 | 16.96 | ND | ND | ND | ND | |
| YFV | 33.18 | 21.18 | 55.52 | 20.97 | 20.86 | 10.90 | 36.52 | 26.17 | 7.68 | 5.94 | |
| ZIKV | 67.19 | 23.70 | 38.71 | 21.76 | 29.25 | 22.80 | 24.62 | 22.46 | 9.21 | 6.91 | |
Infection rate: number of mosquitoes showing virus infection in the gut divided by the number of mosquitoes fed with infected blood x 100. Infection: percentage of mosquitoes in which the virus was detected after 7–10 day of incubation following intrathoracic injection of the indicated virus. For this test, the ground mosquito suspension was inoculated in rats, or the virus presence was quantified by assays in Vero cells. ND: Not described SD: standard deviation AMTV, Arumowot virus; BUJV, Bujaru virus; CHIKV, Chikungunya virus; CVV, Cache Valley virus; CHPV, Chandipura virus; CHIV, Chilibre virus; DENV-1, Dengue virus serotype 1; DENV-2, Dengue virus serotype 2; EEEV, Eastern Equine Encephalomyelitis virus; GETV, Getah virus; ICOV, Icoaraci virus; ITPV, Itaporanga virus; JCV, Jamestown Canyon virus; JEV, Japanese Encephalitis virus; KARV, Karimabad virus; KEYV, Keystone virus; LACV, La Crosse virus; MAYV, Mayaro virus; OROV, Oropuche virus; ORUV, Orungo virus; PACV, Pacui virus; POTV, Potosi virus; RVFV, Rift Valley fever virus; RRV, Ross River virus; SALV, Salehabad virus; SAV, San Angelo virus; SLEV, St. Louis encephalitis virus; TENV, Tensaw virus; TVTV, Trivittatus virus; URUV, Urucuri virus; USUV, Usutu virus; VEEV, Venezuelan equine encephalitis virus; WNV, West Nile virus; YFV, Yellow fever virus; and ZIKV, Zika virus. For BSQV, Bussuquara virus, ILHV, Ilheus virus, KOKV, Kokobera virus, KUNV, Kunjin virus, UGSV, and Uganda S. virus, only transovarial transmission tests were described.
Comparison of the infection rate, dissemination efficiency, and transmission efficiency (mean and standard deviation) for Aedes albopictus and other mosquito vectors.
| Mosquito Species | Virus | IR (%) | DE (%) | TE (%) |
|---|---|---|---|---|
|
| CHIKV | NA | 98.3 ± 3.8 | 42.92 ± 20.19 |
| DENV-1 | 37.7 ± 27 | 34.4 ± 24.9 | 4.9 ± 4.6 | |
| DENV-2 | 44.4 ± 33.4 | 33.3 ± 24.2 | 5 ± 0 | |
| ZIKV | 69.0 ± 27.4 | 44.0 ± 28.3 | 20.48 ± 26.87 | |
| YFV | 46.4.0±23.6 | 21.3 ± 19.0 | 16.5 ± 17.7 | |
|
| CHIKV | 58.9 ± 28.2 | 79.0 ± 23.4 | 42.68 ± 23.7 |
| DENV-1 | 60.2 ± 16 | 39.5 ± 24.2 | 6.25 ± 0 | |
| DENV-2 | 58.0 ± 30.9 | 34.8 ± 18.8 | 10.13 ± 12.28 | |
| WNV | 63.8 ± 29.2 | 58.1 ± 30.8 | 68.6 ± 18.6 | |
| YFV | 33.1 ± 21.1 | 20.8 ± 10.8 | 7.68 ± 5.9 | |
| ZIKV | 67.1 ± 23.7 | 29.2 ± 22.8 | 9.21 ± 6.9 | |
|
| WNV | 47.7 ± 33.7 | 30.4 ± 29.7 | 13.49 ± 14.8 |
|
| YFV | 50.9 ± 4.0 | 30.06 ± 1.6 | 8.08 ± 2.0 |
IR, infection rate; DE, dissemination efficiency; TE, transmission efficiency; CHIKV, Chikungunya virus; DENV-1, Dengue serotype 1; DENV-2, Dengue serotype 2; WNV, West Nile virus; YFV, Yellow fever virus; ZIKV, Zika vírus.